Healthy IndividualsNCT06580171
Validation of Walking and Remembering Test
A study testing Walking and Remembering Test in people with Healthy Individuals, run by Emre Şenocak at 1 site in Turkey (Türkiye).
Trial summary
In this study, the usability of the Walking and Remembering Test will be examined using the remote interview method. The study will be carried out with a single group. First, the WART test will be performed face-to-face at Marmara University Biomechanics Laboratory. Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy Individuals
- What is being tested?
- Walking and Remembering Test
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 29 Jul 2024to 28 Feb 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Having any known psychological, vestibular and neurological diseases,
- No major or minor hip, knee or ankle injuries,
- Not showing osteoarticular or muscle traumas that prevent upright posture and ambulation,
- Not taking medications that affect posture, such as vestibular apparatus sedatives, antidepressants or anxiolytics,
- Not complaining of dizziness or vertigo,
- Being between the ages of 18-30.
Who cannot join
- Individuals with untreated visual impairment,
- Epilepsy, postural dizziness or hypotension,
- Individuals with dependent ambulation,
- Individuals with any disease that affects balance,
- Those with cancer or fibromyalgia.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Marmara University, Department of Physiotherapy and Rehabilitation, Biomechanics and Performance Analysis Laboratory
Istanbul, 34840
About this study
Official title: A Study to Assess The Balance Using Remote Access Method - Walking and Remembering Test Validation
In this study, the usability of the Walking and Remembering Test will be examined using the remote interview method. The study will be carried out with a single group. First, the WART test will be performed face-to-face at Marmara University Biomechanics Laboratory. The second evaluation will be carried out using a remote method. From the participants;
- He/she will first be asked to walk freely within a line that is 8 meters long and 19 cm wide. Later;
- He will be asked to walk once at average speed and three times as fast as possible in the same line. Later;
- The participant is given a Counting Test. This test includes number sequences from 4 digits to 9 digits. Participants are told these number strings and asked to repeat them with the same speed and tone of voice. The longest sequence of numbers is recorded. Later;
- The participant is walked on the same line again and asked to repeat the longest number sequence he remembers and the test is completed. Cognitive performance with the counting test reflects walking speed during 4 walks, and the number of incorrect steps reflects walking performance.
- Conditions
- Healthy Individuals
- Being tested
- Walking and Remembering Test
- Keywords
- Healthy, Walking and Remembering Test, Validity, Tele-assessment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Walking and Remembering TestOther
Only Walking and Remembering Test will be applied to the group.
| Study group | Role | What they receive |
|---|---|---|
| Walking and Remembering Group | Experimental | Only Walking and Remembering Test will be applied to the group. Receives: Other: Walking and Remembering Test |
What is being measured
The primary outcome is the main question the study is designed to answer.
Walking and Remembering Test (WART)
WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance. In the test, walking and memory are observed independently and under dual-task conditions.
Measured: Baseline of the study (Face-to-Face)
Walking and Remembering Test (WART)
WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance. In the test, walking and memory are observed independently and under dual-task conditions.
Measured: First day after the Baseline Assessment (Remote Assessment)
Secondary outcomes (1)
Demographic Data Form
This form was created by researchers and it consist of personal informations such as gender, dominant extremity, history of sport, age, body mass index
Measured: Baseline of the study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Aug 2024
- Study start29 Jul 2024
- Primary completion28 Feb 2025
- Study completion28 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy IndividualsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Walking and Remembering Test Group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Emre Şenocak
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Emre Şenocak, Karadeniz Technical University
- Investigators
- Aysel Yildiz Ozer, Professor, Study chair, Marmara UniversitySemra Oğuz, Associate Professor, Study chair, Marmara UniversityGökçe Kartal, MSc, Study chair, Marmara University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06580171
- Sponsor's protocol ID
- 25.07.2024/112
- Status last verified
- Mar 2025
- First submitted
- 29 Aug 2024
- Last updated
- 7 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Study to Assess The Balance Using Remote Access Method - Walking and Remembering Test Validation
- ClinicalTrials.gov ID
- NCT06580171
- Acronym / sponsor ID
- 25.07.2024/112
- Conditions
- Healthy Individuals
- Keywords
- Healthy, Walking and Remembering Test, Validity, Tele-assessment
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Emre ŞenocakUniversity, hospital or other
- Study start
- 29 Jul 2024 (actual)
- Primary completion
- 28 Feb 2025 (actual)
- Study completion
- 28 Feb 2025 (actual)
- First posted
- 30 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, the usability of the Walking and Remembering Test will be examined using the remote interview method. The study will be carried out with a single group. First, the WART test will be performed face-to-face at Marmara University Biomechanics Laboratory. The second evaluation will be carried out using a remote method. From the participants;
- He/she will first be asked to walk freely within a line that is 8 meters long and 19 cm wide. Later;
- He will be asked to walk once at average speed and three times as fast as possible in the same line. Later;
- The participant is given a Counting Test. This test includes number sequences from 4 digits to 9 digits. Participants are told these number strings and asked to repeat them with the same speed and tone of voice. The longest sequence of numbers is recorded. Later;
- The participant is walked on the same line again and asked to repeat the longest number sequence he remembers and the test is completed. Cognitive performance with the counting test reflects walking speed during 4 walks, and the number of incorrect steps reflects walking performance.
Study design
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Walking and Remembering Test Group
| Arm | Type | Receives |
|---|---|---|
| Walking and Remembering Group | Experimental | Other: Walking and Remembering TestOnly Walking and Remembering Test will be applied to the group. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Having any known psychological, vestibular and neurological diseases,
- No major or minor hip, knee or ankle injuries,
- Not showing osteoarticular or muscle traumas that prevent upright posture and ambulation,
- Not taking medications that affect posture, such as vestibular apparatus sedatives, antidepressants or anxiolytics,
- Not complaining of dizziness or vertigo,
Key exclusion criteria (5 listed)
- Individuals with untreated visual impairment,
- Epilepsy, postural dizziness or hypotension,
- Individuals with dependent ambulation,
- Individuals with any disease that affects balance,
- Those with cancer or fibromyalgia.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Walking and Remembering TestOnly Walking and Remembering Test will be applied to the group. | Other | Walking and Remembering Group |
Primary outcome
Walking and Remembering Test (WART)
Time frame: Baseline of the study (Face-to-Face)
WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance. In the test, walking and memory are observed independently and under dual-task conditions.
Walking and Remembering Test (WART)
Time frame: First day after the Baseline Assessment (Remote Assessment)
WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance. In the test, walking and memory are observed independently and under dual-task conditions.
1 secondary outcome
Demographic Data Form
Time frame: Baseline of the study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Mar 2025.
- Individual participant dataSharing planned: No
Related trials for Healthy Individuals
Recruiting
Metabolic Impact of VLCPUFA-Rich Fish Oil: A Clinical Study on Omega-3 Index Enhancement in Healthy Individuals
Fatty Acids, Omega-3, Fish Oils
Recruiting
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
Type 2 Diabetes, Healhty
Not yet recruitingObservational study
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene
PIEZO2-Deficiency Syndrome
RecruitingPhase 1
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
HIV
Not yet recruiting
Microneedle-based ISF Sampling Technique
No Condition, Healthy Individuals
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Aysel Yildiz Ozer, Professor study chair
Marmara University
Semra Oğuz, Associate Professor study chair
Marmara University
Gökçe Kartal, MSc study chair
Marmara University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Walking and Remembering Test in people with Healthy Individuals, run by Emre Şenocak at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Walking and Remembering Test (WART) (time frame: Baseline of the study (Face-to-Face)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2025.